Status:
COMPLETED
Hemodynamic and Respiratory Tolerance of Intermittent Hemodialysis in Critically Ill Patients
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
Acute kidney injury (AKI) affects up to 30% of critically ill patients and is associated with increased rates of mortality. Up to 60% of patients with AKI will ultimately require renal replacement the...
Detailed Description
In this prospective observational study, investigators aim to characterize the hemodynamic and respiratory tolerances of HDI-bicar and AFB-K in critically ill patients requiring RRT.
Eligibility Criteria
Inclusion
- Patients ≥ 18 years old
- Invasive monitoring of blood pressure
- Non opposition to the research
- Admission to the intensive care unit
- Need of intermittent hemodialysis
Exclusion
- Sodium bicarbonate infusion
- Pregnancy or breastfeeding
- Juridical protection
Key Trial Info
Start Date :
April 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04444765
Start Date
April 23 2020
End Date
December 31 2022
Last Update
July 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Rangueil
Toulouse, France, 31400